Lore Vanderbeke

3.5k total citations
13 papers, 373 citations indexed

About

Lore Vanderbeke is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lore Vanderbeke has authored 13 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lore Vanderbeke's work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (6 papers) and COVID-19 Clinical Research Studies (3 papers). Lore Vanderbeke is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (6 papers) and COVID-19 Clinical Research Studies (3 papers). Lore Vanderbeke collaborates with scholars based in Belgium, United Kingdom and Netherlands. Lore Vanderbeke's co-authors include Joost Wauters, Bart Rijnders, Paul E. Verweij, Isabel Spriet, Christine Breynaert, Katrien Lagrou, Laura Seldeslachts, Yannick Van Herck, Els Wauters and Stéphanie Humblet‐Baron and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and British Journal of Haematology.

In The Last Decade

Lore Vanderbeke

13 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lore Vanderbeke Belgium 9 299 186 59 51 42 13 373
Zahra Abtahian Iran 10 264 0.9× 116 0.6× 30 0.5× 82 1.6× 35 0.8× 27 368
Marion Blaize France 9 321 1.1× 236 1.3× 44 0.7× 16 0.3× 36 0.9× 14 450
Hasan Selçuk Özger Türkiye 9 196 0.7× 66 0.4× 19 0.3× 88 1.7× 28 0.7× 47 340
Wirawan Jeong Australia 6 675 2.3× 414 2.2× 26 0.4× 46 0.9× 10 0.2× 8 740
Ashim Das India 10 636 2.1× 392 2.1× 27 0.5× 44 0.9× 14 0.3× 15 720
Mateja Janković Makek Croatia 10 202 0.7× 249 1.3× 39 0.7× 20 0.4× 9 0.2× 44 356
Tim Flerlage United States 7 128 0.4× 111 0.6× 65 1.1× 21 0.4× 86 2.0× 13 343
Synne Jenum Norway 15 328 1.1× 246 1.3× 21 0.4× 15 0.3× 103 2.5× 34 461
Shu-qing Zhong China 6 254 0.8× 109 0.6× 97 1.6× 94 1.8× 61 1.5× 10 400
Naoki Hosogaya Japan 10 164 0.5× 152 0.8× 41 0.7× 5 0.1× 27 0.6× 49 301

Countries citing papers authored by Lore Vanderbeke

Since Specialization
Citations

This map shows the geographic impact of Lore Vanderbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lore Vanderbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lore Vanderbeke more than expected).

Fields of papers citing papers by Lore Vanderbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lore Vanderbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lore Vanderbeke. The network helps show where Lore Vanderbeke may publish in the future.

Co-authorship network of co-authors of Lore Vanderbeke

This figure shows the co-authorship network connecting the top 25 collaborators of Lore Vanderbeke. A scholar is included among the top collaborators of Lore Vanderbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lore Vanderbeke. Lore Vanderbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Maertens, Luc, et al.. (2024). Severely complicated ear infection in a patient treated with ixekizumab: a case report. European Archives of Oto-Rhino-Laryngology. 281(10). 5549–5553. 2 indexed citations
2.
Feys, Simon, Agostinho Carvalho, Cornelius J. Clancy, et al.. (2024). Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. The Lancet Respiratory Medicine. 12(9). 728–742. 27 indexed citations
3.
Feys, Simon, Katrien Lagrou, Cato Jacobs, et al.. (2023). High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation. Clinical Infectious Diseases. 78(2). 361–370. 21 indexed citations
4.
Vanderbeke, Lore, Cato Jacobs, Simon Feys, et al.. (2023). A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue. American Journal of Respiratory and Critical Care Medicine. 208(3). 301–311. 15 indexed citations
5.
Daele, Ruth Van, Joost Wauters, Erwin Dreesen, et al.. (2022). Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA‐FLU study. Mycoses. 65(6). 656–660. 6 indexed citations
6.
Reséndiz-Sharpe, Agustin, Roberta Peres da Silva, Elena Geib, et al.. (2022). Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis. Disease Models & Mechanisms. 15(3). 17 indexed citations
7.
Cambier, Seppe, Mieke Metzemaekers, Cato Jacobs, et al.. (2021). Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight. 7(1). 39 indexed citations
8.
Seldeslachts, Laura, Lore Vanderbeke, Agustin Reséndiz-Sharpe, et al.. (2021). Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence. 12(1). 2493–2508. 22 indexed citations
9.
Neumann, Julika, Teresa Prezzemolo, Lore Vanderbeke, et al.. (2020). Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19. Clinical & Translational Immunology. 9(11). e1204–e1204. 58 indexed citations
10.
Betrains, Albrecht, Laurent Godinas, Feng Jung Sherida H. Woei-A-Jin, et al.. (2020). Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies. British Journal of Haematology. 192(6). 1100–1105. 39 indexed citations
11.
Vanderbeke, Lore, Eric Van Wijngaerden, Johan Maertens, Joost Wauters, & Katrien Lagrou. (2020). Diagnosis of Invasive Aspergillosis in Intensive Care Unit Patients. Current Fungal Infection Reports. 14(2). 166–173. 2 indexed citations
12.
Vanderbeke, Lore, Isabel Spriet, Christine Breynaert, et al.. (2018). Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Current Opinion in Infectious Diseases. 31(6). 471–480. 121 indexed citations
13.
Vanderbeke, Lore, Willy Peetermans, Veroniek Saegeman, & Paul De Munter. (2016). Q fever: a contemporary case series from a Belgian hospital. Acta Clinica Belgica. 71(5). 290–296. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026